LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2018-11-28
DOI
10.1080/15384047.2018.1529091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy
- (2017) Wei Sun et al. ONCOLOGY REPORTS
- Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
- (2017) Wenrui Wang et al. Cell Death & Disease
- Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer
- (2017) Wenhua Xue et al. Oncotarget
- The Emerging Function and Mechanism of ceRNAs in Cancer
- (2016) Yunfei Wang et al. TRENDS IN GENETICS
- The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer
- (2016) Niu Zequn et al. Oncotarget
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients
- (2016) Ming-Yue Liu et al. Journal of Thoracic Disease
- Extensive microRNA-mediated crosstalk between lncRNAs and mRNAs in mouse embryonic stem cells
- (2015) Jennifer Y. Tan et al. GENOME RESEARCH
- Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER− breast cancer cell lines
- (2015) Qian Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway
- (2015) Ismael Riquelme et al. CELLULAR ONCOLOGY
- Upregulation of microrna-451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis
- (2015) Feng Tian et al. Thoracic Cancer
- LncRNA: A link between RNA and cancer
- (2014) Guodong Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The complexity of miRNA-mediated repression
- (2014) A Wilczynska et al. CELL DEATH AND DIFFERENTIATION
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Considerations when investigating lncRNA function in vivo
- (2014) Andrew R Bassett et al. eLife
- The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and Therapy
- (2013) X. Pan et al. MOLECULAR CANCER THERAPEUTICS
- The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
- (2013) Yong Yang et al. PLoS One
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
- (2012) Martina Redova et al. Journal of Translational Medicine
- Pathology of Lung Cancer
- (2011) William D. Travis CLINICS IN CHEST MEDICINE
- Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
- (2011) Xiaoyu Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials
- (2011) AYAKO MATSUDA et al. Experimental and Therapeutic Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now